Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.810
-0.070 (-2.43%)
At close: Jan 20, 2026, 4:00 PM EST
2.780
-0.030 (-1.07%)
After-hours: Jan 20, 2026, 7:08 PM EST
Cardiff Oncology Employees
As of December 31, 2024, Cardiff Oncology had 33 total employees, including 32 full-time and 1 part-time employees. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$15,182
Profits / Employee
-$1,528,667
Market Cap
189.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 33 | 1 | 3.13% | 32 | 1 |
| Dec 31, 2023 | 32 | 6 | 23.08% | 31 | 1 |
| Dec 31, 2022 | 26 | 3 | 13.04% | 25 | 1 |
| Dec 31, 2021 | 23 | 11 | 91.67% | 22 | 1 |
| Dec 31, 2020 | 12 | -2 | -14.29% | 11 | 1 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Coherus Oncology | 228 |
| Humacyte | 220 |
| Zentalis Pharmaceuticals | 166 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
| Quince Therapeutics | 36 |
| Galectin Therapeutics | 15 |
CRDF News
- 7 days ago - Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm - Seeking Alpha
- 6 weeks ago - Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 - GlobeNewsWire
- 6 weeks ago - Cardiff Oncology to Present at Sidoti's Year-End Virtual Investor Conference - GlobeNewsWire
- 2 months ago - Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Cardiff Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Cardiff Oncology: Preparing For A Defining 2026 - Seeking Alpha
- 3 months ago - Cardiff Oncology's Promising Cancer Breakthrough Ahead - Why I Choose To Buy - Seeking Alpha